首页> 外文会议>International Conference on Bioinformatics and Biomedical Engineering >Antitumor Activity of Escin in Mice Cervical Carcinoma U_(14) in vivo and Human Cervical Carcinoma Hela Cell Line in vitro
【24h】

Antitumor Activity of Escin in Mice Cervical Carcinoma U_(14) in vivo and Human Cervical Carcinoma Hela Cell Line in vitro

机译:凯森宫颈颈癌癌患者的抗肿瘤活性(14)在体外体内和人宫颈癌Hela细胞系中

获取原文

摘要

Pollution made cancer a major disease threatening people's health. In the search for new cancer drug treatments, natural products perform an essential role. Escin, a mixture of triterpene saponins extracted from Aesculus Wilsonii Rehd., was used to analyze the cell growth inhibitory effects and the induction of apoptosis in human cervical carcinoma Hela cancer cell line in vitro. The results of MTT cell viability assay showed that escin could induce significant concentration-dependent and time-dependent inhibition of cell growth, and the cell cycle was arrested at G_1/S phase in the escin-treated cells. Apoptosis were detected and assessed by Acridine Orange/Ethidium Bromide Staining and Flow Cytometry. The antitumor efficacy of escin on mice cervical carcinoma U_(14) in vivo was investigated, at dose of 2.8 mg/kg escin had rather high inhibition ratio(43.5%) on U_(14) tumor growth.
机译:污染使癌症成为威胁人民健康的主要疾病。在寻找新的癌症药物治疗中,天然产品表现了重要作用。 Escin,从AeSculus Wilsonii Rehd中提取的三萜皂苷的混合物用于分析体外人宫颈癌Hela癌细胞系中细胞生长抑制作用和凋亡诱导。 MTT细胞活力测定的结果表明,ESCIN可以诱导显着的浓度依赖性和时间依赖性抑制细胞生长,并且细胞周期在谢内处理的细胞中在G_1 / S期被捕。通过吖啶橙/乙锭染色和流式细胞术检测和评估细胞凋亡。研究了Escin对小鼠宫颈癌U_(14)的抗肿瘤疗效,在2.8mg / kg escin的剂量下进行了相当高的U_(14)肿瘤生长的抑制率(43.5%)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号